Genome-mining-guided discovery of coumarubrin: A novel aminocoumarin-substituted rubromycin antibiotic
Journal of Industrial Microbiology and Biotechnology · 2024
DOI: 10.1093/jimb/kuaf018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Industrial Microbiology and Biotechnology, 2024. Verfasst von Heiner G Weddeling und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Aminocoumarins. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Swiss National Science Foundation.
Abstract (Originalsprache)
Rubromycins are bacterial aromatic polyketides containing a hallmark spiroketal pharmacophore produced by type II polyketide synthases and accessory enzymes. They generally display cytotoxic and antimicrobial properties, frequently disrupting cellular processes and proteins associated with nucleic acids, such as DNA helicase or telomerase. Among the known rubromycin congeners, hyaluromycin stands out due to a 2-amino-3-hydroxycyclopent-2-enone (C5N) substitution that is presumably installed by an amide bond synthetase (ABS). Here, we used bioinformatic analysis to identify uncharacterized biosynthetic gene clusters and potential rubromycin producer strains encoding putative ABSs but lacking the enzymes responsible for C5N formation, suggesting potentially novel substituents. One of these strains, Lentzea tibetensis, was successfully cultivated and confirmed to produce a previously undescribed aminocoumarin-substituted rubromycin polyketide, named coumarubrin, as verified by high-resolution mass spectrometry (HRMS) and comprehensive nuclear magnetic resonance (NMR) spectroscopy. Electronic circular dichroism spectroscopy indicates an absolute configuration identical to that of previously characterized rubromycins, while the first bioactivity assays demonstrated potent inhibitory activity against Gram-positive bacteria. One-Sentence Summary: This study reports the discovery of a novel member of the rubromycins, antibiotic and cytotoxic aromatic polyketides produced by Actinobacteria, which is fused to a distinct aminocoumarin moiety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Biology, Department of Pharmaceutical Sciences, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland.
ORCID-Profile: Heiner G Weddeling, Robin Teufel
Förderung
- Swiss National Science Foundation
Zitieren
APA
Weddeling, H. G., Sowa, S. T., Bosshardt, S., Schwimbersky, L., Rakhmanov, M., & Teufel, R. (2024). Genome-mining-guided discovery of coumarubrin: A novel aminocoumarin-substituted rubromycin antibiotic. Journal of Industrial Microbiology and Biotechnology. https://doi.org/10.1093/jimb/kuaf018
Vancouver
Weddeling HG, Sowa ST, Bosshardt S, Schwimbersky L, Rakhmanov M, Teufel R. Genome-mining-guided discovery of coumarubrin: A novel aminocoumarin-substituted rubromycin antibiotic. Journal of Industrial Microbiology and Biotechnology. 2024. doi:10.1093/jimb/kuaf018
BibTeX
@article{Weddeling2024,
author = {Weddeling, Heiner G and Sowa, Sven T and Bosshardt, Selina and Schwimbersky, Lukas and Rakhmanov, Malik and Teufel, Robin},
title = {Genome-mining-guided discovery of coumarubrin: A novel aminocoumarin-substituted rubromycin antibiotic},
journal = {Journal of Industrial Microbiology and Biotechnology},
year = {2024},
doi = {10.1093/jimb/kuaf018}
}
EUVIMED